Fulcrum Therapeutics, Inc. Common Stock (FULC) News

Latest headlines that mention FULC, newest first · each headline opens the original publisher

FULC quote

Last price: $3.71
Day change: +0.14%
Next earnings: 2026-11-04

Quote & chart Expected move Insider trading IV rank history

FULC headlines

latest coverage

Yahoo Finance 1mo ago

Fulcrum (FULC) is Allocating 95% of the Combined Company to Slate and PIPE Investors. Is the $270M Dividend Enough?

General T2FULC

Yahoo Finance 2mo ago

Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies

General T2FULC

Yahoo Finance 2mo ago

Fulcrum Therapeutics Merges With Slate in $245M Migraine Biotech Deal

General T2FULC

Investing.com 2mo ago

Why is Fulcrum Therapeutics stock rallying today?

General T3FULC

Seeking Alpha 2mo ago

Fulcrum Therapeutics, Slate Medicines to merge in all-stock deal

General T2FULC

Seeking Alpha News 2mo ago

Fulcrum Therapeutics: Buy It For The Strategic Reset

General T2FULC

Investing.com 3mo ago

Form 4 Fulcrum Therapeutics Inc For: 15 July

General T3FULC

Investing.com 4mo ago

Goldman Sachs drops Fulcrum Therapeutics stock coverage after trial halt

General T3FULC GS

Investing.com 4mo ago

Stifel cuts Fulcrum Therapeutics stock rating on drug discontinuation

General T3FULC SF

FULC news alerts

Get an alert by email or push when a new headline mentions FULC.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.